New risk score aims to improve heart bypass outcomes in brazil

NCT ID NCT07293533

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: University of Sao Paulo General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a risk score called CABG-BraSCORE to better predict outcomes for people having coronary artery bypass surgery in Brazil. Researchers will collect data from 2,400 patients across multiple hospitals to see how factors like age and health affect risks like death or long hospital stays. The goal is to help hospitals improve care and make fairer payment decisions based on patient risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a more accurate risk score for heart bypass patients in Brazil, helping hospitals improve care and adjust payments fairly.
What could go wrong: This is an observational study, not a treatment trial. The risk score may not work well in all hospitals or may need further validation before use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CABG-PATIENTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CABG-PATIENTS

Contacts and locations

Locations

Beneficência Portuguesa de São Paulo

São Paulo, 01323-001, Brazil
Hospital Alberto Urquiza Wanderley

João Pessoa, Paraíba, 58040-300, Brazil
Hospital de Messejana

Fortaleza, Ceará, Brazil
Instituto Nacional de Cardiologia de Laranjeiras

Rio de Janeiro, 22240-002, Brazil
USP Heart Institute

São Paulo, São Paulo, 05403-900, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.